Raymond James & Associates Recursion Pharmaceuticals, Inc. Transaction History

Raymond James & Associates

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$7.35 - $10.05 $273,853 - $374,452	37,259 Added 98.97%	74,905 $561,000
Q1 2024 Apr 22, 2024	BUY	$9.13 - $15.52 $343,707 - $584,265	37,646 New	37,646 $375,000
Q3 2023 Oct 24, 2023	BUY	$6.59 - $15.86 $455,948 - $1.1 Million	69,188 New	69,188 $529,000

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.41B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.